Drugs / Novel oral poliomyelitis vaccine type 1 (nOPV1)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06137664 | Nov 2024 → Dec 2027 expected | poliomyelitis | PATH | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novel oral poliomyelitis vaccine type 1 (nOPV1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06137664 ↗ |
| Known as | nOPV1 | “Novel oral poliomyelitis vaccine type 1 (nOPV1)” NCT06137664 ↗ |
| Route | Oral | “Novel oral poliomyelitis vaccine type 1 (nOPV1)” NCT06137664 ↗ |